Current Evaluation of Amenorrhea

    October 2006 in “ Fertility and Sterility ”
    Image of study
    TLDR The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.
    The 2006 document by the Practice Committee of the American Society for Reproductive Medicine provides an overview of the evaluation of amenorrhea, distinguishing between primary and secondary amenorrhea and noting a prevalence of 3% to 4% for non-pregnancy, non-lactation, and non-menopause related cases. It identifies polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure as the most common causes. The evaluation process includes a history and physical examination, along with measurement of FSH, TSH, and prolactin levels. The document highlights the need for a karyotype in women under 30 with ovarian failure and the consideration of autoimmune and genetic factors in premature ovarian failure. It also discusses the differentiation between hypothalamic amenorrhea and PCOS, the risk of osteoporosis, and the potential need for estrogen-progestin therapy or ovulation induction. Screening for type 2 diabetes in women with PCOS is recommended, emphasizing the importance of identifying the underlying cause of amenorrhea for appropriate treatment.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 16 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 9 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Sugar and Hair loss connections

      in Research/Science  41 upvotes 2 weeks ago
      High sugar diets may worsen hair loss by increasing 5α-reductase activity and androgen levels, especially in women with PCOS. A low sugar diet might reduce scalp DHT levels, similar to finasteride, but genetics also significantly influence hair loss.

      community C’est terrible - at my wits end

      in Female  450 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

    Related Research

    1 / 1 results